Spyridon Papapetropoulos
Vermogen: 145 533 $ op 31-08-2026
Vermogen: 145 533 $ op 31-08-2026
Dr. Spyridon Papapetropoulos is a Chief Executive Officer & Executive Director at Neuphoria Therapeutics, Inc., a President, Chief Executive Officer & Director at Bionomics Ltd. and a President at Encephalos Life Sciences LLC.
He is on the Board of Directors at Neuphoria Therapeutics, Inc. and Bionomics Ltd. Dr. Papapetropoulos was previously employed as a Chairman by Lipocine, Inc., an Independent Director by Adamas Pharmaceuticals LLC, a Chief Medical Officer by Vigil Neuroscience, Inc., a Chief Development Officer, SVP & Head-Development by ACADIA Pharmaceuticals, Inc., a Chief Executive Officer by SwanBio Therapeutics, Inc., and a Chief Medical Officer & EVP-R&D by Cavion, Inc. He received his doctorate degree from the University of Patras and a doctorate degree from Semmelweis University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,32% | 16-04-2025 | 5.999.940 ( 0,32% ) | 124 079 $ | 31-08-2026 |
0,09% | 17-09-2026 | 4.944 ( 0,09% ) | 18 589 $ | 31-08-2026 |
LIPOCINE INC 0,02% | 04-06-2025 | 1.279 ( 0,02% ) | 2 865 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Encephalos Life Sciences LLC
Encephalos Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences consulting firm | Oprichter | - |
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Algemeen Directeur | 05-01-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| LIPOCINE INC. | Voorzitter | 16-04-2026 |
| VIGIL NEUROSCIENCE, INC. | Hoofd Techniek/Wetenschap/O&O | 04-01-2023 |
| ADAMAS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 24-11-2021 |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Algemeen Directeur | 01-10-2020 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01-09-2020 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 10 |
|---|---|
ACADIA Pharmaceuticals, Inc.
ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Cavion, Inc.
Cavion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology drugs for solid tumors | Health Technology |
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
University of Patras
University of Patras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Semmelweis University
Semmelweis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lipocine, Inc.
Lipocine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in research and development for the delivery of drugs | Health Technology |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Health Technology |
Encephalos Life Sciences LLC
Encephalos Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences consulting firm | Commercial Services |
Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau